Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
WisdomTree Europe SmallCap Dividend Fund
DFE
$169M
| $695K | ﹤0.01% |
+17,100
| New | +$967K |
|
2602
Flanigan's Enterprises
BDL
$84.1M
| $694K | ﹤0.01% |
59,800
+2,000
| +3% | +$37.2K |
|
|
PRVB
2603
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $688K | ﹤0.01% |
+74,796
| New | +$964K |
|
2604
AMREP Corp
AXR
$120M
| $687K | ﹤0.01% |
143,100
-4,880
| -3% | -$27.7K |
|
2605
Everspin Technologies
MRAM
$404M
| $687K | ﹤0.01% |
+262,225
| New | +$1.04M |
|
|
TRT
2606
Trio-Tech International
TRT
$113M
| $687K | ﹤0.01% |
510,760
-18,600
| -4% | -$35.5K |
|
2607
Boston Omaha
BOC
$434M
| $686K | ﹤0.01% |
37,900
+15,800
| +71% | +$303K |
|
|
NEPT
2608
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $686K | ﹤0.01% |
417
+279
| +202% | +$794K |
|
2609
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
| $685K | ﹤0.01% |
11,600
-11,200
| -49% | -$844K |
|
2610
The Joint Corp
JYNT
$116M
| $684K | ﹤0.01% |
63,078
+19,490
| +45% | +$286K |
|
2611
Global X SuperDividend ETF
SDIV
$1.21B
| $683K | ﹤0.01% |
24,433
+17,400
| +247% | +$791K |
|
2612
AMCON Distributing
DIT
| $682K | ﹤0.01% |
16,230
-15
| -0.1% | -$733 |
|
2613
AXT Inc
AXTI
$5.5B
| $681K | ﹤0.01% |
212,000
+23,500
| +12% | +$86.6K |
|
|
ONIT
2614
Onity Group
ONIT
$326M
| $680K | ﹤0.01% |
90,660
+6,209
| +7% | +$110K |
|
|
GFED
2615
DELISTED
Guaranty Federal Bancshares In
GFED
| $674K | ﹤0.01% |
45,300
-729
| -2% | -$16.2K |
|
2616
Aptevo Therapeutics
APVO
$5.15M
| – | – |
0
| – | – |
|
2617
ManpowerGroup
MAN
$2.66B
| $670K | ﹤0.01% |
+12,652
| New | +$1.05M |
|
2618
OSI Systems
OSIS
$3.89B
| $669K | ﹤0.01% |
9,700
-45,071
| -82% | -$3.85M |
|
|
CLSD
2619
DELISTED
Clearside Biomedical
CLSD
| $668K | ﹤0.01% |
26,193
+20,280
| +343% | +$750K |
|
|
ASPU
2620
DELISTED
ASPEN GROUP, INC.
ASPU
| $668K | ﹤0.01% |
83,667
-10,577
| -11% | -$88.6K |
|
|
MFNC
2621
DELISTED
Mackinac Financial Corporation
MFNC
| $668K | ﹤0.01% |
63,968
-22,801
| -26% | -$325K |
|
2622
Pathward Financial
CASH
$1.83B
| $667K | ﹤0.01% |
+30,700
| New | +$1.01M |
|
2623
OneSpaWorld
OSW
$2.68B
| $667K | ﹤0.01% |
164,300
+109,900
| +202% | +$1.32M |
|
2624
NLI Holdings
NL
$310M
| $666K | ﹤0.01% |
223,514
-14,690
| -6% | -$48.9K |
|
2625
Vanguard International High Dividend Yield ETF
VYMI
$20.9B
| $666K | ﹤0.01% |
+14,700
| New | +$839K |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.